On Thursday shares of Cytokinetics, Incorporated (NASDAQ:CYTK) closed at $5.99. Company’s sales growth for last 5 years was -10.50% and EPS growth for next 5 years is recorded as 15.00%. On April 30, Cytokinetics, Incorporated (NASDAQ:CYTK) reported total research and development revenues for the first quarter of 2015 were $4.4 million, compared to $8.0 million during the same period in 2014. The net loss for the first quarter was $8.9 million, or $0.23 per basic and diluted share. This is compared to a net loss for the same period in 2014, of $8.7 million, or $0.27 per basic share and diluted share. As of March 31, 2015, cash, cash equivalents and investments totaled $117.5 million.
Benefitfocus, Inc. (NASDAQ:BNFT) in last trading activity advanced 9.10% to close at $36.21. Company weekly performance is 4.80% while its quarterly performance stands at 54.74%. Benefitfocus, Inc. (NASDAQ:BNFT) is -26.61% away from its 52 week high. Benefitfocus, Inc. (NASDAQ:BNFT) announced that its Chief Financial Officer, Milt Alpern, will present at the Jefferies 2015 TMT Conference in Miami. The Benefitfocus presentation is scheduled for Tuesday, May 12, 2015 at 3:30 p.m. Eastern Time.
On last trading day Merchants Bancshares Inc. (NASDAQ:MBVT) advanced 0.31% to close at $29.45. Its volatility for the week is 1.18% while volatility for the month is 2.01%. MBVT’s sales growth for past 5 years was -5.10% and its EPS growth for past 5 years was -1.30%. Merchants Bancshares Inc. (NASDAQ:MBVT) monthly performance is -1.34%. Merchants Merchants Bancshares Inc. (NASDAQ:MBVT) begin trading ex-dividend on May 07, 2015. A cash dividend payment of $0.28 per share is scheduled to be paid on May 25, 2015.
Anworth Mortgage Asset Corporation (NYSE:ANH) has 2.40% insider ownership while its institutional ownership stands at 67.60%. In last trading activity company’s stock closed at $5.11. Anworth Mortgage Asset (NYSE:ANH) was upgraded by Zacks from a “hold” rating to a “buy” rating in a report issued on Wednesday. The firm currently has a $5.75 target price on the stock. Zacks‘s price objective would suggest a potential upside of 12.97% from the company’s current price.
On last trading day Canadian Pacific Railway Limited (NYSE:CP) advanced 0.96% to close at $189.10. Its volatility for the week is 2.54% while volatility for the month is 2.14%. CP’s sales growth for past 5 years was 8.50% and its EPS growth for past 5 years was 20.80%. Canadian Pacific Railway Limited (NYSE:CP) monthly performance is 2.48%. Canadian Pacific (NYSE:CP) announced that Mark Erceg has been appointed Executive Vice-President and Chief Financial Officer effective May 18, 2015.